Thomas Roland Insel[1] | |
---|---|
Born | |
Alma mater | Boston University (B.A.) Boston University (M.D.) |
Known for | Research on oxytocin and vasopressin and their impact on social behavior |
Scientific career | |
Institutions | National Institute of Mental Health Emory University |
Notes | |
Paul A. Insel (brother) |
Thomas Roland Insel (born October 19, 1951) is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health (NIMH) from 2002 until November 2015.[2] Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia.[3][4] He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment.[5][6] He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X (now Verily Life Sciences).[7] On May 8, 2017, CNBC reported that he had left Verily Life Sciences.[8] Insel is a Co-founder with Richard Klausner and Paul Dagum of a digital mental health company named "Mindstrong,"[9] a Bay-area startup. He has also co-founded Humanest Care, NeuraWell Therapeutics, and MindSite News and is a member of the scientific advisory board for Compass Pathways, a company that is developing the psychedelic drug psilocybin to treat depression and other mental health disorders. His book, Healing: Our Path from Mental Illness to Mental Health was published by Penguin Random House in February, 2022.